Articles Archives - Page 7 of 697

FridayMar 07, 2025 10:00 am

Adageis Secures $2M Seed Funding to Expand AI-Driven Healthcare Solutions

Adageis closed a $2 million seed round at the end of Q4 2024 to support operational expansion, with the funding to enhance backend operations for next-generation software upgrades. Upgraded Electronic Health Record EHR”) connectivity will facilitate integration with over 90 EHR systems, while increased sales force investment will help accelerate growth and market adoption. Adageis' AI-powered platform is designed to streamline healthcare operations, optimize provider revenue, and improve patient care outcomes. Adageis, a forward-thinking healthcare technology company reshaping patient care through flexible AI-centric software solutions for healthcare organizations, has secured $2 million in seed financing to enhance its operations and…

ThursdayMar 06, 2025 10:45 am

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Looks to Benefit from Higher Palladium Price

One industry expert projects that the price of palladium could double within the next decade. The projected increase in palladium prices bodes well for PLG. To further strengthen its strategic position, PLG has been exploring opportunities to enhance its processing capabilities. The palladium market may be poised for a transformation over the next decade, with one industry analyst forecasting a price increase. The anticipated higher price would present a promising opportunity for companies deeply invested in palladium, such as Platinum Group Metals (NYSE American: PLG) (TSX: PTM). As an emerging player in the palladium sector, Platinum Group Metals stands to…

WednesdayMar 05, 2025 11:30 am

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Pioneers Systemic Virotherapy with RTNova Platform

Calidi's RTNova platform leverages engineered enveloped vaccinia viruses designed for systemic delivery. Calidi's groundbreaking virotherapy holds “immense promise in revolutionizing the treatment landscape for cancer patients with advanced solid tumors,” says CEO. Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage biotechnology company at the forefront of developing innovative immunotherapies for cancer treatment. Most recently, the company has captured the spotlight for the development of its proprietary systemic platform, RTNova (https://ibn.fm/Z4pM3). The platform represents a significant advancement in systemic virotherapy, particularly in the utilization of enveloped virotherapies to target metastatic tumors across the body. Antitumor virotherapy employs viruses that selectively infect…

WednesdayMar 05, 2025 10:45 am

Clene Inc. (NASDAQ: CLNN) to Highlight Latest Achievements, Next Steps for CNM-Au8(R), at Q1 Virtual Investor Summit on March 11

The Q1 Virtual Investor Summit will focus on microcap companies that are undervalued, and aim to create connections between leading investors and microcap companies Clene’s presentation will be given by CEO Rob Etherington and CFO Morgan Brown Clene’s participation in the event comes as the company is moving closer to submitting a New Drug Application to the FDA to secure potential accelerated approval for CNM-Au8® for ALS The company recently partnered with German-based APST Research GmbH to analyze neurofilament light chain (“NfL”) data for evaluating CNM-Au8 efficacy in ALS patients. Clene Inc. (NASDAQ: CLNN) and its wholly owned subsidiary, Clene…

TuesdayMar 04, 2025 11:30 am

Thumzup Media Corp. (NASDAQ: TZUP) is Democratizing the $200 Billion Social Media Advertising Industry

A hidden investor opportunity, Thumzup Media Corporation is starting to overturn the social media branding and marketing industry with an innovative approach to small business advertising The company expects to grow its advertiser network 10x by the end of the year, the first step toward getting 10% of America’s small businesses to advertise on the platform and directing 20% of their ad budgets to Thumzup This goal follows the 230% advertiser base growth seen in 2024, coupled with the company’s market expansion to South Florida and Greater Los Angeles Thumzup (NASDAQ: TZUP), a Los Angeles-based company, is democratizing the $200…

TuesdayMar 04, 2025 10:45 am

Get Ready for The Pennsylvania Cannabis Convention: A Hub for Cannabis Innovation and Networking

The Pennsylvania Cannabis Convention (“PACC”) is gearing up to bring together growers, traders, brands, and enthusiasts to explore the legal cannabis sector in Pennsylvania on March 30, 2025. This event is a must-visit for those involved in the local cannabis industry, offering attendees in-depth insights into every aspect of the PA medical program. Registrations are open, and PA patients can attend the PACC for free. For the March 30 event, PACC has partnered with NECANN, a renowned leader in hosting cannabis networking events. NECANN events are recognized as some of the premier cannabis gatherings on the East Coast, providing high…

TuesdayMar 04, 2025 10:00 am

Driving Digital Transformation in Medical Affairs: Key Takeaways from the 9th Digital Strategy and Innovation Summit

The 9th Digital Strategy & Innovation for Medical Affairs Summit, held on February 26-27, 2025, in Philadelphia, brought together industry leaders to explore the transformative role of digital technologies in medical affairs. The event featured insightful discussions on artificial intelligence (“AI”), patient engagement, and innovative strategies to navigate the evolving technological landscape. Key Sessions and Speakers: Bridge Patient Care Gaps with AI-Driven, Omnichannel Engagement: This session delved into how AI-powered strategies are revolutionizing healthcare professional (“HCP”) engagement to address patient care gaps. Speakers included: Kyle Roderick, SVP of Medical Affairs at Doximity Amit Phull, Chief Physician Experience Officer at Doximity…

MondayMar 03, 2025 12:45 pm

Brera Holdings PLC (NASDAQ: BREA) Soccer Clubs Close Winter 2024-2025 Transfer Window with 10 New Signings; Affirms Commitment to Building Competitive Squads with Diverse International Talent

Brera Holdings, an Ireland-based, international holding company with a global portfolio of men’s and women’s sports clubs, just closed 10 new signings for its clubs in the 2024-2025 transfer window, 8 for the men’s teams and 2 for the women’s teams The company’s management believes that these new signings will bring fresh energy and expertise to their respective teams, positioning them for a successful second half of the season The signings follow an independent CFA’s valuation report projecting Brera’s revenues will triple in 2025 Brera Holdings (NASDAQ: BREA), an Ireland-based, international holding company focused on expanding its global portfolio of…

FridayFeb 28, 2025 12:20 pm

Forschungszentrum Jülich Becomes First High-Performance Computing Center to Own a D-Wave Quantum Inc. (NYSE: QBTS) Advantage System

Forschungszentrum Jülich scientists have already leveraged D-Wave's technology for research on protein folding, electron interactions and quantum physics. The Advantage™ system features over 5,000 qubits and 15-way connectivity, advancing quantum optimization research. The quantum system will be linked to JUPITER, Europe’s first exascale supercomputer, potentially enabling novel computational applications. The system will be upgraded to D-Wave’s next-generation Advantage2™ quantum processor when available, which D-Wave expects will deliver doubled coherence time, higher qubit connectivity and 40% improvement in energy scaling. The collaboration is anticipated to take the use of quantum technology to a new level, according to Prof. Kristel Michielsen, head…

FridayFeb 28, 2025 11:00 am

Clene Inc. (NASDAQ: CLNN) Leverages APST’s NfL Database to Support FDA-Recommended Analyses for ALS Drug

Clene is partnering with APST Research GmbH to analyze neurofilament light chain (“NfL”) data for evaluating CNM-Au8® in ALS patients. APST maintains one of the largest ALS biomarker databases, with data from over 4,300 ALS patients, including clinical outcomes and biomarker tracking. The analysis will compare NfL changes in the NIH-sponsored Expanded Access Program (“EAP”) participants with historical ALS patient data to assess CNM-Au8’s potential efficacy. Clene plans to submit its statistical analysis plan to the FDA, aiming for filing of an NDA for potential accelerated approval in the second half of 2025. No significant safety concerns have been reported…

Site Search

Company Search

Category: Articles